Publications

• Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation.
  J Appl Lab Med Volume: 8 Page(s): 1074 - 1083
  11/02/2023 Authors: Raghavendran P; Tillman BF; Wheeler AP; Gailani D
• MANAGEMENT OF PATIENTS AT RISK FOR TUMOR LYSIS: A QUALITY INITIATIVE TO DECREASE UNNECESSARY CARE
  Volume: 70 Page(s): S53 - S54
  06/01/2023 Authors: Tanaka K; Raghavendran P; Hall L; Timaeus S; Esbenshade A; Smith C
• EVALUATING CHROMOGENIC AND CLOT-BASED DRUG CONCENTRATION ASSAYS FOR BIVALIRUDIN MONITORING
  Volume: 98 Page(s): E88 - E88
  02/01/2023 Authors: Raghavendran P; Borst A; Tillman B; Wheeler A; Gailani D
• Clinical Response to PI3K- Inhibition in a Cohort of Children and Adults With PIK3CA-Related Overgrowth Spectrum Disorders.
  J Vasc Anom (Phila) Volume: 3
  03/01/2022 Authors: Raghavendran P; Albers SE; Phillips JD; Zarnegar-Lumley S; Borst AJ
• EVALUATION AND MANAGEMENT OF CLINICALLY DYNAMIC EPIDURAL HEMATOMA USING TELEHEALTH
  Volume: 48
  01/01/2020 Authors: Raghavendran P; McSwain S; Marvin W
• Transitions of Care for Healthy Young Adults: Promoting Primary Care and Preventive Health.
  South Med J Volume: 112 Page(s): 497 - 499
  09/01/2019 Authors: Graves L; Leung S; Raghavendran P; Mennito S
• Outcomes of Using IVC Filters in Patients with Malignancy at an Academic Medical Center.
  TH Open Volume: 3 Page(s): e117 - e122
  04/01/2019 Authors: Raghavendran P; Lim MY
• EXPLORING THE RATIONALE AND OUTCOMES OF VENA CAVA FILTER PLACEMENT IN PATIENTS WITH MALIGNANCY
  Volume: 93 Page(s): E54 - E54
  09/01/2018 Authors: Raghavendran P; Lim MY